Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study

BACKGROUND: The aim of the study was to evaluate the performance of the 2MACE in patients with atrial fibrillation (AF) treated with rivaroxaban and to improve the accuracy of 2MACE. METHODS: This was a post-authorization and observational study of AF adults treated with rivaroxaban for ≥ 6 months....

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández, Marcelo Sanmartín, Sánchez, Manuel Anguita, Arribas, Fernando, Barón-Esquivias, Gonzalo, Barrios, Vivencio, Cosin-Sales, Juan, Esteve-Pastor, María Asunción, Freixa-Pamias, Roman, Lekuona, Iñaki, Pérez-Cabeza, Alejandro I., Ureña, Isabel, Rodríguez, José Manuel Vázquez, Priu, Carles Rafols, Marin, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2022
Materias:
Clinical Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273239/
https://www.ncbi.nlm.nih.gov/pubmed/35621092
http://dx.doi.org/10.5603/CJ.a2022.0044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273239/
https://www.ncbi.nlm.nih.gov/pubmed/35621092
http://dx.doi.org/10.5603/CJ.a2022.0044

Ejemplares similares